OWC Pharmaceutical Research Corp (OWCP)

[Triple9]

Revenue from the consulting contracts, the sale of skin cremes, and licensing of the sublingual tablet will put us in Dollarville. $2-7, IMHO, easy.

Starting Phase 1 FDA trials for psoriasis creme, skin cancer creme, Multiple Myeloma sublingual tablet, and/or PTSD sublingual tablet will, IMHO, put us above $10.

Once those trials go well and we start Phase 2 FDA trials, I'm thinking $20+.

By then the pro analysts will have initiated coverage and there we be a share price consensus. Institutional owners will step up and how high it can go is anyone's guess.